Evidence map›Paper›PMID 27842589›Full record

ArticleBMC endocrine disorders2016

The course of diabetes in children, adolescents and young adults: does the autoimmunity status matter?

Rasa Verkauskiene, Evalda Danyte, Rimante Dobrovolskiene, Ingrida Stankute, Diana Simoniene, Dovile Razanskaite-Virbickiene, Audrone Seibokaite, Brone Urbonaite, Nijole Jurgeviciene, Astra Vitkauskiene and 2 more

Open access · goldAbstract read
In one paragraph

Article in BMC endocrine disorders, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 2 pooled it
1.2field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 2 syntheses or guidelines pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Rasa VerkauskieneInstitute of Endocrinology, Medical Academy, Lithuanian University of Health Sciences, Eiveniu 2, LT-50161, Kaunas, Lithuania. rasa.verkauskiene@kaunoklinikos.lt.
Evalda DanyteInstitute of Endocrinology, Medical Academy, Lithuanian University of Health Sciences, Eiveniu 2, LT-50161, Kaunas, Lithuania.
Rimante DobrovolskieneDepartment of Endocrinology, Hospital of Lithuanian University of Health Sciences Kauno Klinikos, LT-50161, Kaunas, Lithuania.
Ingrida StankuteDepartment of Endocrinology, Hospital of Lithuanian University of Health Sciences Kauno Klinikos, LT-50161, Kaunas, Lithuania.
Diana SimonieneDepartment of Endocrinology, Hospital of Lithuanian University of Health Sciences Kauno Klinikos, LT-50161, Kaunas, Lithuania.
Dovile Razanskaite-VirbickieneDepartment of Endocrinology, Hospital of Lithuanian University of Health Sciences Kauno Klinikos, LT-50161, Kaunas, Lithuania.
Audrone SeibokaiteInstitute of Endocrinology, Medical Academy, Lithuanian University of Health Sciences, Eiveniu 2, LT-50161, Kaunas, Lithuania.
Brone UrbonaiteInstitute of Endocrinology, Medical Academy, Lithuanian University of Health Sciences, Eiveniu 2, LT-50161, Kaunas, Lithuania.
Nijole JurgevicieneInstitute of Endocrinology, Medical Academy, Lithuanian University of Health Sciences, Eiveniu 2, LT-50161, Kaunas, Lithuania.
Astra VitkauskieneDepartment of Endocrinology, Hospital of Lithuanian University of Health Sciences Kauno Klinikos, LT-50161, Kaunas, Lithuania.
Valerie SchwitzgebelDepartment of Child and Adolescent, University Hospital of Geneva, 1211, Geneva, Switzerland.
Dalia MarciulionyteInstitute of Endocrinology, Medical Academy, Lithuanian University of Health Sciences, Eiveniu 2, LT-50161, Kaunas, Lithuania.
Lithuanian University of Health Sciences · LTHospital of Lithuanian University of Health Sciences Kaunas Clinics · LTUniversity of Geneva · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundInitial classification of diabetes of young may require revision to improve diagnostic accuracy of different forms of diabetes. The aim of our study was to examine markers of beta-cell autoimmunity in a cohort of young (0-25 years) patients with type 1 diabetes and compare the presentation and course of the disease according to the presence of pancreatic antibodies.

methodsCross-sectional population-based study was performed covering 100% of pediatric (n = 860) and 70% of 18-25 years old adult patients (n = 349) with type 1 diabetes in Lithuania.

resultsNo antibodies (GAD65, IA-2, IAA and ICA) were found in 87 (7.5%) cases. Familial history of diabetes was more frequent in those with antibodies-negative diabetes (24.1 vs. 9.4%, p < 0.001). Gestational age, birth weight and age at diagnosis was similar in both groups. Ketosis at presentation was more frequent in patients with autoimmune diabetes (88.1 vs. 73.5%, p < 0.05). HbA1c at the moment of investigation was 8.6 (3) vs. 8.7 (2.2)% in antibodies-negative and antibodies-positive diabetes groups, respectively, p > 0.05. In the whole cohort, neuropathy was found in 8.8% and nephropathy - in 8.1% of cases, not depending on autoimmunity status. Adjusted for age at onset, disease duration and HbA1c, retinopathy was more frequent in antibodies-negative subjects (13.8 vs. 7.8%, p < 0.05).

conclusionAntibodies-negative pediatric and young adult patients with type 1 diabetes in this study had higher incidence of family history of diabetes, higher frequency of retinopathy, less frequent ketosis at presentation, but similar age at onset, HbA1c, incidence of nephropathy and neuropathy compared to antibodies-positive patients.

Indexed as

AutoimmunityAdolescentAdultChildChild, PreschoolCohort StudiesCross-Sectional StudiesDiabetes Mellitus, Type 1Diabetic KetoacidosisDiabetic RetinopathyDisease ProgressionFemaleGlycated HemoglobinHumansInfantInfant, NewbornGlycated Hemoglobinhemoglobin A1c protein, humanAdolescentsChildrenPancreatic antibodiesType 1 diabetesYoung adults

Identifiers

PMID27842589
PMCPMC5109672
OpenAlexW2555341966

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.